InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51
United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Christopher R. Fenimore
2 Nov 2026
EVP Finance CFO
Exercised, kept
6,000
$381.92
$2.29M
Andrew J Murphy
13 Oct 2026
Co-Chief Scientific Officer
Exercised, kept
17,000
$381.92
$6.49M
Joseph J Larosa
19 Aug 2026
EVP General Counsel and Secret
Exercised, kept
12,282
$381.92
$4.69M
Christopher R. Fenimore
18 Aug 2026
EVP Finance CFO
Exercised, kept
6,283
$381.92
$2.40M
George L Sing
30 Dec 2025
Director
Exercised, kept
9,212
$520.01
$4.79M
Leonard S Schleifer
9 Dec 2025
Bd. Co-Chair, President & CEO
Exercised, kept
172,723
$555.67
$95.98M
George Yancopoulos
9 Dec 2025
Bd. Co-Chair, President & CSO
Exercised, kept
146,815
$555.67
$81.58M
Joseph J Larosa
20 Nov 2025
EVP General Counsel and Secret
Exercised, kept
14,450
$555.67
$8.03M
Christine A Poon
30 Oct 2025
Director
Exercised, kept
2,712
$520.01
$1.41M
Andrew J Murphy
29 Oct 2025
EVP Research
Exercised, kept
35,000
$555.67
$19.45M
George L Sing
31 Dec 2024
Director
Exercised, kept
3,338
$413.33
$1.38M
Andrew J Murphy
13 Aug 2024
EVP Research
Exercised, kept
20,000
$399.66
$7.99M
Neil Stahl
2 Aug 2024
EVP Research and Development
Exercised, kept
23,638
$555.67
$13.13M
Showing 250 of 2,711 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 681
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 490
Sales straight out of an exercise 615
Sales at will 1,347
Transactions with no price 0
Shares from compensation/vesting 22,169,618
Sales filed before the plan box existed 1,292
History held since 3 Oct 2006